Researchers based in Germany have developed a perfusion process for the manufacture of oncolytic viruses. The team from the Max Planck Institute says that the new approach aims to improve virus titers ...
Recombinant adeno-associated virus (rAAV) is currently used as vector in about 250 clinical trials for gene therapy (Bulcha et al., 2021). Nonetheless, there are still several challenges concerning ...
BOSTON--(BUSINESS WIRE)--908 Devices Inc., (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announced that National Resilience, Inc.
The demand for producing therapeutic recombinant proteins is generating a renewed interest in perfusion cell culture technologies, leading to the development of cell culture media that can support ...
Continuous bioprocessing PAT requires real-time sensors and closed-loop control to maintain steady-state culture conditions.
SUZHOU, China and HANGZHOU, China, Sept. 15, 2020 /PRNewswire/ -- Transcenta, a global biotherapeutics company, today announced success in scaling up the continuous perfusion process to 200L and ...
Process analytical technology enables data-driven scale-up by embedding real-time analytics from development through ...
Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry today announced the launch of the ambr ® 250 high throughput (ht) perfusion, a new automated ...
Potential for improved product quality and cost/time savings is reviving interest in perfusion technology. Perfusion technology was first introduced in the late 1980s to boost the low product ...
Potential for improved product quality and cost/time savings is reviving interest in perfusion technology. Perfusion technology was first introduced in the late 1980s to boost the low product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results